Episode summary
Taking Bold Bets: NIH and the Future of Biomedical Science
The a16z Show
· · Hosts: Erik Torenberg · Guests: Jay Bhattacharya, Vineeta Agarwala, Jorge Conde
Summary
The discussion centers on how the NIH can be made more dynamic, more rigorous, and more responsive to major public health problems. The host and the guest discuss new autism research initiatives, including $50 million in funding for 13 teams, alongside two related moves: updated caution around acetaminophen use in pregnancy and expanded access to leucovorin for some autistic children with folate-processing issues. The guest argues that the public deserves careful, evidence-based guidance rather than panic, and that the NIH should back large, auditable science programs aimed at real-world outcomes.
A major theme is the “replication crisis” and the claim that biomedical science has become too conservative. The guest says the NIH should reward replication, support productive failure, and fund younger investigators more aggressively instead of over-weighting established labs and old ideas. He also argues that NIH allocation should be informed both by scientific opportunity and by public priorities, especially in areas like chronic disease, preterm birth, cancer, diabetes, and declining life expectancy.
The conversation also covers academic freedom, public trust, and AI. The guest says internal NIH researchers should not need permission to publish, journals should be more open, and public health must regain trust by admitting uncertainty when evidence is thin. He sees AI as a powerful tool for summarizing knowledge, helping radiology and administrative work, and accelerating drug discovery, but not as a substitute for scientists.
Key takeaways
- The guest says the NIH is launching a $50 million autism data science initiative and will grant 13 teams funding, while also updating guidance on acetaminophen in pregnancy.
- He argues that the NIH should reward replication and productive failure, because too much biomedical research is built on old ideas and insufficiently validated results.
- The guest says the NIH should fund more early-career investigators and judge institute directors on the portfolio as a whole, not just individual grant outcomes.
- He links declining U.S. life expectancy to chronic disease burdens and says NIH priorities should better reflect conditions like heart disease, diabetes, cancer, and preterm birth.
- He says AI should augment scientists and clinicians, not replace them, and could help with drug discovery, radiology, and administrative burdens.
Notable quotes
“We should stop punishing scientists who fail. If they fail productively, let them publish in a journal that explain why they're what they what they learn from it”
“the standard for truth in science ought to be replication. Independent teams you don't just don't believe me just cuz I haven't I say something is true”
“we need kind of that Silicon Valley spirit so that and we should stop punishing scientists who fail”
“I think AI is really important as I said I think it's but it has to we have to do research to understand how it can be used to help people”
How the episode opens
The American people are not stupid. In fact, they're quite smart. And when we talk to them in ways where we show respect for their intelligence with data, allow people to disagree, but then have the evidence right there in front of people, I think people people will respond with trust where the evidence actually leads.
We need kind of that Silicon Valley spirit. We should stop punishing scientists who fail. If they fail productively, let them publish in a journal that explain why they're what they what they learn from it.
like that Silicon Valley spirit I think needs to come to science a little bit more. Well, Dr. Bart, thank you so much for for coming on the podcast.
We're we're stoked to have you. I'm I'm delighted to be here. So good to talk with you.
I'm a little jealous I'm not in Menlo Park to be there with you on this. So, yeah, exactly. And and we're talking Monday, September 22nd.
Um there's there's big news coming out today. Um the the Times uh piece on on you just came out. I want you to reflect on on that as well.
But maybe you can uh you could share with us the the big news and why it's so impactful. Sure. Uh so six months ago, roughly six months ago when I first started this job, uh Secretary Kennedy challenged me to help get answers for families with autistic kids.
I mean was there's uh the prevalence has been rising for decades. Like one in 31 kids, I think was the CDC's latest numbers on this. That's that's an incredible number.
Um and we don't have answers. A lot of times families, they have these behavioral therapies that don't really work very well for a lot of their kids.
From the episode’s captions: roughly the first two minutes, lightly cleaned. Keep watching on YouTube →
Topics
- nih funding
- autism research
- replication crisis
- academic freedom publishing
- ai in science
Watch the episode
Watch “Taking Bold Bets: NIH and the Future of Biomedical Science” on YouTube
Summary, takeaways and quote selection by Octagon. Quotes are short excerpts; the full conversation is in the episode.
More from The a16z Show
-
How AI Could Bring Halo and Other Classic Games Back to Life -
Mike Volpi on Why AI Infrastructure Will Outlast the Hype Cycle -
Why HubSpot’s Co-Founder Is Betting Against the SaaSpocalypse -
Inside Salesforce’s Acquisition Strategy for the AI Era -
How AI Is Turning Figma’s Finance Team Into Builders -
The New AI Agents That Shop, Plan, and Gossip
The a16z Show, this episode and its artwork belong to Andreessen Horowitz. Octagon is not affiliated with the show; this page is an independent summary.
